uftoral has been researched along with Tongue Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, H; Inokuchi, T; Irie, A; Mizoguchi, Y; Shibahara, K; Takebe, Y; Yamada, K | 1 |
| Ikemura, K; Oya, R | 1 |
2 other study(ies) available for uftoral and Tongue Neoplasms
| Article | Year |
|---|---|
[A case report of tongue squamous cell carcinoma showing a complete response to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Oxonic Acid; Pyridines; Remission Induction; Tegafur; Tongue Neoplasms; Uracil | 2003 |
Spontaneous regression of recurrent squamous cell carcinoma of the tongue.
Topics: Aged; Carcinoma, Squamous Cell; Drug Combinations; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous; Tegafur; Tongue Neoplasms; Uracil | 2004 |